HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yung Hyun Choi Selected Research

indirubin-3'-monoxime

1/2021Indirubin-3'-monoxime induces paraptosis in MDA-MB-231 breast cancer cells by transmitting Ca2+ from endoplasmic reticulum to mitochondria.
9/2019p53-Mediated Oxidative Stress Enhances Indirubin-3'-Monoxime-Induced Apoptosis in HCT116 Colon Cancer Cells by Upregulating Death Receptor 5 and TNF-Related Apoptosis-Inducing Ligand Expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yung Hyun Choi Research Topics

Disease

233Neoplasms (Cancer)
06/2022 - 12/2002
56Leukemia
01/2021 - 05/2005
52Carcinoma (Carcinomatosis)
03/2021 - 05/2002
44Urinary Bladder Neoplasms (Bladder Cancer)
06/2022 - 05/2006
37Inflammation (Inflammations)
09/2021 - 01/2006
35Mitochondrial Diseases (Mitochondrial Disease)
09/2022 - 11/2007
31Hepatocellular Carcinoma (Hepatoma)
10/2021 - 01/2006
24Breast Neoplasms (Breast Cancer)
01/2021 - 02/2004
22Neoplasm Metastasis (Metastasis)
03/2020 - 09/2005
18Prostatic Neoplasms (Prostate Cancer)
03/2022 - 01/2003
15Melanoma (Melanoma, Malignant)
07/2021 - 12/2004
15Lung Neoplasms (Lung Cancer)
08/2020 - 05/2002
14Colonic Neoplasms (Colon Cancer)
12/2019 - 11/2003
12Non-Muscle Invasive Bladder Neoplasms
07/2021 - 01/2010
9Infections
07/2022 - 11/2013
9Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2002
9Neurodegenerative Diseases (Neurodegenerative Disease)
11/2016 - 06/2007
7Stomach Neoplasms (Stomach Cancer)
03/2021 - 02/2011
7Necrosis
01/2021 - 05/2006
7Hypoxia (Hypoxemia)
04/2019 - 11/2009
7Renal Cell Carcinoma (Grawitz Tumor)
11/2018 - 06/2010
7Adenocarcinoma
03/2014 - 11/2007
6Bone Resorption
02/2022 - 12/2017
6Asthma (Bronchial Asthma)
12/2019 - 03/2008
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 08/2005
5Skin Diseases (Skin Disease)
09/2022 - 09/2013
5Rheumatoid Arthritis
05/2021 - 09/2007
5Weight Loss (Weight Reduction)
07/2020 - 11/2019
5Squamous Cell Carcinoma of Head and Neck
01/2017 - 01/2015
4Hyperplasia
03/2022 - 09/2007
4Hemorrhage
01/2022 - 05/2006

Drug/Important Bio-Agent (IBA)

50Proteins (Proteins, Gene)FDA Link
11/2021 - 11/2007
38Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020 - 12/2006
37Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 05/2002
36CaspasesIBA
05/2022 - 12/2003
22NF-kappa B (NF-kB)IBA
06/2020 - 10/2003
21CytokinesIBA
05/2021 - 12/2006
21LigandsIBA
06/2019 - 05/2007
20Matrix Metalloproteinases (MMPs)IBA
06/2022 - 11/2008
19Ethanol (Ethyl Alcohol)IBA
06/2022 - 05/2006
19Caspase 3 (Caspase-3)IBA
01/2020 - 11/2003
17Pharmaceutical PreparationsIBA
06/2022 - 05/2006
17Telomerase (Telomerase Reverse Transcriptase)IBA
03/2015 - 04/2005
16DNA (Deoxyribonucleic Acid)IBA
11/2020 - 10/2004
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2019 - 04/2006
13AntioxidantsIBA
04/2021 - 05/2006
13Anthocyanins (Anthocyanin)IBA
03/2021 - 04/2009
12Cytochromes c (Cytochrome c)IBA
01/2022 - 02/2006
12Messenger RNA (mRNA)IBA
07/2021 - 04/2006
11LipopolysaccharidesIBA
05/2021 - 01/2008
11FlavonoidsIBA
01/2021 - 12/2008
11Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2020 - 04/2004
11ResveratrolIBA
05/2019 - 01/2003
11beta-lapachoneIBA
02/2016 - 03/2003
10AlkaloidsIBA
01/2021 - 01/2008
9Biomarkers (Surrogate Marker)IBA
03/2022 - 07/2016
9Biological ProductsIBA
10/2021 - 08/2004
9sulforaphaneIBA
09/2020 - 05/2007
9cordycepinIBA
01/2019 - 12/2010
8Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2018 - 10/2010
8sanguinarineIBA
01/2016 - 09/2007
7MicroRNAs (MicroRNA)IBA
07/2022 - 10/2016
7Bile Acids and Salts (Bile Acids)IBA
06/2022 - 09/2003
7Transcription Factors (Transcription Factor)IBA
10/2021 - 11/2009
7TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2021 - 02/2008
7Antineoplastic Agents (Antineoplastics)IBA
11/2020 - 04/2012
7PolyphenolsIBA
01/2020 - 05/2006
7esculetinIBA
05/2016 - 03/2008
6Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2015
6Peptides (Polypeptides)IBA
11/2020 - 01/2008
6Caspase 9IBA
01/2020 - 03/2009
6Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2019 - 02/2009
6CurcuminIBA
05/2019 - 05/2006
6morinIBA
05/2019 - 10/2014
6Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019 - 01/2003
6baicaleinIBA
01/2019 - 01/2006
6p38 Mitogen-Activated Protein KinasesIBA
01/2015 - 07/2009
6quinone (benzoquinone)IBA
01/2015 - 11/2003
5bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
11/2021 - 02/2008
5Particulate MatterIBA
08/2021 - 07/2020
5Melanins (Melanin)IBA
07/2021 - 10/2010
5Auranofin (Ridaura)FDA Link
05/2021 - 04/2017
5Therapeutic UsesIBA
12/2019 - 04/2006
5GenisteinIBA
08/2019 - 11/2007
5Bee Venoms (Bee Venom)IBA
01/2019 - 12/2006
5Dinoprostone (PGE2)FDA Link
10/2018 - 06/2007
5buteinIBA
02/2018 - 12/2009
5isothiocyanic acidIBA
01/2018 - 07/2007
5Histone Deacetylase InhibitorsIBA
01/2015 - 08/2005
5HS 1200IBA
10/2008 - 09/2003
5Chenodeoxycholic Acid (Chenix)FDA Link
10/2008 - 09/2003
5OvalbuminIBA
10/2008 - 01/2008
4fisetinIBA
01/2022 - 01/2020
4Oxygen (Dioxygen)IBA
11/2021 - 03/2013
4JNK Mitogen-Activated Protein KinasesIBA
10/2021 - 11/2005
4CateninsIBA
10/2021 - 01/2020

Therapy/Procedure

22Therapeutics
02/2021 - 09/2003
14Traditional Medicine (Folk Remedies)
03/2020 - 06/2008
6Oral Administration
08/2021 - 04/2012
6Drug Therapy (Chemotherapy)
06/2008 - 04/2006